FDA
-
-
-
-
-
-
-
Tryp Therapeutics Announces Q1 2022 Financial Results
-
-
-
-
-
-
-
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders
-
-
-
-
-
-
-
Tryp Therapeutics Partners with Fluence for Psychotherapy Design
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

